Raafat Attia Hanna
Endocrinology, Diabetes & Metabolism · Plymouth, MANPI 1922150804
Payments from drug & device makers
Across 307 payments — averaging $15.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$806
- Johnson & Johnson$676
- AbbVie$520
- Boehringer Ingelheim$517
- AstraZeneca$373
- Novo Nordisk$280
- plus $2K from 23 others
What the payments were for
- Food & beverage$4,75297%
- Education$1513%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 54 | $806 |
| Johnson & Johnson | 51 | $676 |
| AbbVie(2 entities) | 48 | $520 |
| Boehringer Ingelheim | 27 | $517 |
| AstraZeneca(2 entities) | 22 | $373 |
| Novo Nordisk | 13 | $280 |
| Sanofi-aventis U.S. LLC | 10 | $202 |
| Lilly USA, LLC | 10 | $182 |
| Merck | 11 | $178 |
| Amarin Pharma, Inc. | 10 | $161 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $110 |
| Novartis | 7 | $107 |
| Antares Pharma, Inc. | 5 | $99 |
| Insmed, Inc. | 2 | $94 |
| Astellas Pharma US Inc | 3 | $89 |
| Exact Sciences | 1 | $62 |
| Eisai Inc. | 3 | $58 |
| Kowa Pharmaceuticals America, Inc. | 4 | $58 |
| Valeritas, Inc. | 3 | $56 |
| E.r. Squibb & Sons, L.L.C. | 3 | $51 |
| Amgen | 2 | $36 |
| Ultragenyx Pharmaceutical Inc. | 2 | $34 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| Clarus Therapeutics Inc. | 2 | $24 |
| Abbott | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Corcept Therapeutics | 1 | $21 |
| Shire North American Group Inc | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$4,903 in reported general payments places this provider in the 65th percentile of 360 endocrinology, diabetes & metabolism providers in Massachusetts.
See all endocrinology, diabetes & metabolism providers in Massachusetts →
Other endocrinology, diabetes & metabolism in Plymouth
- David NathanBoston$9M
- Vanita ArodaBoston$4.2M
- George KingBoston$3.7M
- Karen MillerBoston$2.9M
- Steven GrinspoonBoston$2.7M
- Jason GagliaBoston$2.5M
- Tamer YacoubFall River$1.4M
- Elaine YuBoston$1.3M
- Osama HamdyBoston$1.1M
- Steven RussellBoston$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.